|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/00 | |
| G01N 31/00 | |||
| C07K 1/00 | |||
| A61P 37/00 | |||
| C07K 16/24 |
| (11) | Patento numeris | 2089428 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 07852953.4 |
| Europos patento paraiškos padavimo data | 2007-10-25 | |
| (97) | Europos patento paraiškos paskelbimo data | 2009-08-19 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2013-11-20 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2007/022622 |
| Data | 2007-10-25 |
| (87) | Numeris | WO 2008/057240 |
| Data | 2008-05-15 |
| (30) | Numeris | Data | Šalis |
| 855104 P | 2006-10-27 | US |
| (72) |
BORHANI, David W., US
FRAUNHOFER, Wolfgang, US
KRAUSE, Hans-Juergen, DE
KOENIGSDORFER, Anette, DE
WINTER, Gerhard, DE
GOTTSCHALK, Stefan, DE
|
| (73) |
AbbVie Biotechnology Ltd,
Clarendon House 2, Church Street, HM 11 Hamilton,
BM
|
| (54) | CRYSTALLINE ANTI-HTNFALPHA ANTIBODIES |
| CRYSTALLINE ANTI-HTNFALPHA ANTIBODIES |